The treatment of Hepatitis B Minor Tri-Yang is mainly aimed at reducing the damage of Hepatitis B virus to the liver, and a complete cure may be less likely, but the condition can be controlled and the impact on the liver can be reduced. Hepatitis B minor triple positive refers to hepatitis B surface antigen positive, hepatitis B e antibody positive and hepatitis B core antibody positive, indicating that at this point in time hepatitis B patients have viral replication, but with a low level of activity. Hepatitis B is usually treated by taking blocking drugs such as lamivudine, adefovir, entecavir or nucleoside analogs under the guidance of a doctor to inhibit the virus from replicating in the body so as to reduce the effect of the virus on hepatitis B. The treatment of Hepatitis B minor triangles is usually based on the use of drugs that inhibit the replication of the virus in the body. The possibility of a complete cure is low, but if the liver is less affected or the presence of the virus in the body is reduced, it is very possible. It is recommended not to give up treatment just because it is not curable, but to actively cooperate with the doctor’s guidance, so as to improve the quality of life and prolong the survival time.